Coagulation studies are NOT required before performance of the<unk> Incidence of clinically significant bleeding complications is low even if in liver failure with an elevated INR (< 0.2%)
No data supports cutoff values beyond which paracentesis should be avoided/prophylactically transfused
Routine use of FFP and platelets is not recommended<unk> is contraindicated if the<unk> is actively bleeding or in DIC
Incidence of clinically significant bleeding complications is low even if in liver failure with an elevated INR (< 0.2%)
Procedures in patients with coagulopathies
Immunocompromised antibiotics
Pregnancy and lactation drug labeling
Conducted energy device
Bioterrorism antibiotics
Safety at sea
Environmental exposure antibiotics
Healthcare occupational exposure to blood or other body fluids